Thesecond-generationhumanpapillomavirus(HPV)vaccinedevelopedinChinahasbeenofficiallyapprovedbytheChinaFoodandDrugAdministration(CFDA)forclinicaltesting,accordin
GlaxoSmithKline's human papilloma virus vaccine has been approved for sale, China Food and Drug Administration told Xinhua on Monday.